Fig. 1From: Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapyCumulative incidence of bRFS among patients in favourable and unfavourable intermediate-riskBack to article page